Tway Air Co Ltd (091810)
Korea Stock Exchange · Korea · prices in KRW · close of 20 Oct 2026
Key indicators
| Last close | KRW 2,420.00 |
|---|---|
| 52-week range | 2,350.00 – 9,175.25 |
| Return, 1 month / 3 months | −10.9% / −37.1% |
| Return, 1 year / 3 years | −71.8% / −82.8% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 54.8% |
| Worst drawdown (1 year) | -73.5% |
| Average daily value traded | 149.83M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
T'way Air is a low-cost airline based in Korea that carries passengers on domestic flights within the country and on international services to destinations across Asia and further afield. The carrier focuses on affordable air travel, serving leisure and business travellers with a fleet of narrow-body aircraft. Its operations centre on Korean airports, with a route network that connects smaller and major cities at home and abroad, and it offers ancillary services such as seat selection and onboard refreshments.
On this site Tway Air Co Ltd appears as a stock on the Korea Stock Exchange (Korea), code 091810, with prices in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tway Air Co Ltd (091810) trades on the Korea Stock Exchange in Korea. It last closed at KRW 2,420.00 on 20 October 2026.
Its price-based Market X-Ray is 13 out of 100 (a weak price profile), ranking 907 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 71.8% and over the last three months it fell 37.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -50.0% | ||
| From 52-week high | -73.5% | ||
| Momentum | 4 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -37.1% | ||
| 6-month return | -56.2% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 54.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -73.5% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 149.83M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −10.9% |
| 3 months | −37.1% |
| 6 months | −56.2% |
| 1 year | −71.8% |
| 3 years | −82.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2,738.80 / 4,837.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 109.54 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.